SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-122785
Filing Date
2021-04-20
Accepted
2021-04-20 16:06:03
Documents
13
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A d52089dpre14a.htm PRE 14A 484390
2 GRAPHIC g52089g00i67.jpg GRAPHIC 1566
3 GRAPHIC g52089g19b10.jpg GRAPHIC 1578
4 GRAPHIC g52089g28m20.jpg GRAPHIC 86038
5 GRAPHIC g52089g36g68.jpg GRAPHIC 4687
6 GRAPHIC g52089g38m12.jpg GRAPHIC 1198
7 GRAPHIC g52089g47n28.jpg GRAPHIC 872
8 GRAPHIC g52089g47w03.jpg GRAPHIC 6447
9 GRAPHIC g52089g61y41.jpg GRAPHIC 861
10 GRAPHIC g52089g62f45.jpg GRAPHIC 1128
11 GRAPHIC g52089g96h47.jpg GRAPHIC 1240
12 GRAPHIC g52089g96v26.jpg GRAPHIC 1575
13 GRAPHIC g52089new001.jpg GRAPHIC 8207
  Complete submission text file 0001193125-21-122785.txt   646110
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35670 | Film No.: 21837901
SIC: 2834 Pharmaceutical Preparations